Ritlecitinib for treating severe alopecia areata in people 12 years and over

Final draft guidance

Final draft guidance (PDF 321 KB)

Committee papers - ACM2 (PDF 2.89 MB)

Public committee slides - ACM2 (PDF 630 KB)

Equality impact assessment (PDF Version) (PDF 168 KB)

Register of interests (PDF 298 KB)

Draft guidance

Public committee slides - ACM1 (PDF 1011 KB)

Draft guidance (PDF version) - Equality Impact Assessment (PDF 154 KB)

Draft guidance (PDF version) (PDF 331 KB)

Draft guidance (online commenting)

Committee papers - ACM1 (PDF 9.01 MB)

Committee meeting: 2

Topic Register of Interest (MSWord 47 KB)

Final stakeholder list (PDF 153 KB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 350 KB)

Equality impact assessment (Scoping) (PDF 164 KB)

Final scope (PDF 166 KB)

Draft matrix post referral (PDF 153 KB)

Draft scope post referral (PDF 164 KB)